Relative risk of death by active treatment rate of district
| Relative risk | ||||
|---|---|---|---|---|
| Group | Overall ATR | Number | Unadjusted (95% CI) | Adjusted for age (95% CI) |
| All lung cancer | <42% | 2942 | 1.00 | 1.00 |
| 42–48% | 7433 | 0.96 (0.92 to 1.00) | 0.95 (0.91 to 1.00) | |
| 48–54% | 5424 | 0.91 (0.88 to 0.95) | 0.93 (0.89 to 0.96) | |
| >54% | 6855 | 0.88 (0.85 to 0.91) | 0.88 (0.85 to 0.91) | |
| Small cell lung cancer | <42% | 267 | 1.00 | 1.00 |
| 42–48% | 696 | 0.93 (0.80 to 1.08) | 0.91 (0.78 to 1.06) | |
| 48–54% | 675 | 0.92 (0.82 to 1.04) | 0.92 (0.82 to 1.03) | |
| >54% | 810 | 0.96 (0.86 to 1.07) | 0.96 (0.86 to 1.08) | |
| Non-small cell lung cancer | <42% | 992 | 1.00 | 1.00 |
| 42–48% | 2760 | 0.94 (0.88 to 1.00) | 0.93 (0.88 to 0.99) | |
| 48–54% | 1862 | 0.88 (0.83 to 0.92) | 0.89 (0.85 to 0.94) | |
| >54% | 2022 | 0.88 (0.84 to 0.93) | 0.88 (0.83 to 0.92) | |
| Clinically diagnosed lung cancer | <42% | 1683 | 1.00 | 1.00 |
| 42–48% | 3977 | 0.99 (0.92 to 1.06) | 0.99 (0.92 to 1.06) | |
| 48–54% | 2887 | 0.97 (0.91 to 1.03) | 0.97 (0.91 to 1.03) | |
| >54% | 4023 | 0.92 (0.87 to 0.98) | 0.92 (0.86 to 0.98) | |